Efficacy, safety, and quality-of-life outcomes with nemolizumab in atopic dermatitis: a meta-analysis of randomized controlled trials
Archives of Dermatological Research · 20.07.2026 · 318 (1)
DOI: 10.1007/s00403-026-04760-y ↗Kurz gefasst
Metaanalyse in der Zeitschrift Archives of Dermatological Research, online erschienen am 20.07.2026. Verfasst von Medisiana Sukses Soenoe und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Soenoe, M. S., & Hadi, S. (2026). Efficacy, safety, and quality-of-life outcomes with nemolizumab in atopic dermatitis: a meta-analysis of randomized controlled trials. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04760-y
Vancouver
Soenoe MS, Hadi S. Efficacy, safety, and quality-of-life outcomes with nemolizumab in atopic dermatitis: a meta-analysis of randomized controlled trials. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04760-y
BibTeX
@article{Soenoe2026,
author = {Soenoe, Medisiana Sukses and Hadi, Sukses},
title = {Efficacy, safety, and quality-of-life outcomes with nemolizumab in atopic dermatitis: a meta-analysis of randomized controlled trials},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04760-y}
}
EUVIMED